Denali Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.About DNLI
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.
CEORyan J. Watts
CEORyan J. Watts
Employees422
Employees422
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2013
Founded2013
Employees422
Employees422
DNLI Key Statistics
Market cap2.13B
Market cap2.13B
Price-Earnings ratio-5.50
Price-Earnings ratio-5.50
Dividend yield—
Dividend yield—
Average volume1.72M
Average volume1.72M
High today$15.00
High today$15.00
Low today$14.67
Low today$14.67
Open price$14.94
Open price$14.94
Volume613.14K
Volume613.14K
52 Week high$33.33
52 Week high$33.33
52 Week low$10.57
52 Week low$10.57
DNLI News
Simply Wall St 4d
Denali Therapeutics Insiders Sell US$1.9m Of Stock, Possibly Signalling CautionThe fact that multiple Denali Therapeutics Inc. ( ) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongs...
Analyst ratings
100%
of 18 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own DNLI. This list is generated using Robinhood data, and it’s not a recommendation.